Abonnement à la biblothèque: Guest
Journal of Environmental Pathology, Toxicology and Oncology

Publication de 4  numéros par an

ISSN Imprimer: 0731-8898

ISSN En ligne: 2162-6537

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.4 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.8 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.5 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00049 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.59 SJR: 0.429 SNIP: 0.507 CiteScore™:: 3.9 H-Index: 49

Indexed in

Malvidin Abrogates Oxidative Stress and Inflammatory Mediators to Inhibit Solid and Ascitic Tumor Development in Mice

Volume 39, Numéro 3, 2020, pp. 247-260
DOI: 10.1615/JEnvironPatholToxicolOncol.2020034430
Get accessGet access

RÉSUMÉ

The anticancer activity of malvidin was studied in Dalton's lymphoma ascites (DLA)-induced solid and ascitic tumor mice models. Malvidin is a natural compound belonging to the family of O-methylated anthocyanidin and plays a predominant role in regulating both short- and long-term cellular activities. Animals were injected with DLA cells (1.5 × 106 cells/animal) to induce solid and ascitic tumors. The administration of malvidin (5 mg/kg bw and 10 mg/kg bw) was carried out for 10 consecutive days from the day of tumor induction for both solid and ascitic tumors. Cyclophosphamide, CTX (25 mg/kg bw), used as the standard drug, was also administered for 10 consecutive days. Treatment with malvidin showed a significant reduction in tumor volume and elevated white blood cell (WBC) count when compared to the DLA-bearing control animals. The treatment also maintained the body weight and hemoglobin level, and decreases in aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT) were also noted. This investigation also reported the decreased levels of cellular glutathione (GSH) in ascitic tumor groups. Malvidin reduced inflammatory mediator and cytokine levels, such as tumor necrosis factor level alpha (TNF-α) and interleukin-6 (IL-6), which serve as molecular targets for cancer prevention. A decrease in the level of reactive oxygen species (ROS), like nitric oxide (NO), was observed. Histopathological examination revealed altered morphological changes in tumor tissue and the alleviation of hepatic architecture due to DLA. Immunohistochemical analysis revealed the inhibition of iNOS. This study demonstrated that malvidin exhibited significant in vivo antitumor activity and that it was reasonably imputable to its increasing endogenous mechanism. We accent the pertinence of malvidin as a potential naturally derived drug target for tumor control.

RÉFÉRENCES
  1. Shoemaker RH, Fox JT, Juliana MM, Moeinpour FL, Grubbs CJ. Evaluation of the STAT3 inhibitor GLG-302 for the prevention of estrogen receptor-positive and negative mammary cancers. Oncol Rep. 2019;42(3):1205-13.

  2. Hartner L. Chemotherapy for oral cancer. Dent Clin. 2018;62(1):87-97.

  3. Sharma V, Gupta SK, Verma M. Dihydropyrimidine dehy- drogenase in the metabolism of the anticancer drugs. Cancer Chemother Pharmacol. 2019:84(1):1157-66.

  4. Mazza G. Compositional and functional properties of saskatoon berry and blueberry. Int J Fruit Sci. 2005;5(3): 101-20.

  5. Anna MB, Myles M, Paul K Survey of bioactive compo-nents in Western Canadian berries. Can J Physiol Pharm. 2007;85(11):1139-52.

  6. Nizamutdinova IT, Kim YM, Chung JI, Shin SC, Jeong YK, Seo HG, Lee JH, Chang KC, Kim HJ. Anthocyanins from black soybean seed coats preferentially inhibit TNF-a-mediated induction of VCAM-1 over ICAM-1 through the regulation of GATAs and IRF. J Agric Food Chem. 2009;57(16):7324-30.

  7. Routray W, Orsat V. Blueberries and their anthocyanins: factors affecting biosynthesis and properties. Compr Rev Food Sci Food Saf. 2011;10(6):303-20.

  8. Huang W, Zhu Y, Li C, Sui Z, Min W. Effect of blueberry anthocyanins malvidin and glycosides on the antioxidant properties in endothelial cells. Oxidative Med Cell Longevity. 2016. Article ID 1591803:1-10.

  9. Chai H, Wang Q, Huang L, Xie T, Fu Y. Ginsenoside Rb1 inhibits tumor necrosis factor-a-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Biol Pharm Bull. 2008;31(11):2050-56.

  10. Kavitha K, Thiyagarajan P, Rathna J, Mishra R, Nagini S. Chemopreventive effects of diverse dietary phyto-chemicals against DMBA-induced hamster buccal pouch carcinogenesis via the induction of Nrf2-mediated cyto-protective antioxidant, detoxification, and DNA repair enzymes. Biochimie. 2013;95(8):1629-39.

  11. Baba AB, Kowshik J, Krishnaraj J, Sophia J, Dixit M, Nagini S. Blueberry inhibits invasion and angiogenesis in 7, 12-dimethylbenz [a] anthracene (DMBA)-induced oral squamous cell carcinogenesis in hamsters via suppression of TGF-P and NF-KB signaling pathways. J Nutr Biochem. 2016;35(1):37-47.

  12. Baba AB, Nivetha R, Chattopadhyay I, Nagini S. Blueberry and malvidin inhibit cell cycle progression and induce mitochondrial-mediated apoptosis by abrogating the JAK/STAT-3 signalling pathway. Food Chem Toxicol. 2017;109(1):534-43.

  13. Zhuang C, Guan X, Ma H, Cong H, Zhang W, Miao Z. Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment. Eur J Med Chem. 2019;163(1): 883-95.

  14. Oliveira H, Wu N, Zhang Q, Wang J, Oliveira J, de Freitas V, Mateus N, He J, Fernandes I. Bioavailability studies and anticancer properties of malvidin based anthocyanins, pyranoanthocyanins and non-oxonium derivatives. Food Funct. 2016;7(5):2462-68.

  15. Wang Y, Lin J, Tian J, Si X, Jiao X, Zhang, W, Gong E, Li B. Blueberry malvidin-3-galactoside suppresses hepato-cellular carcinoma by regulating apoptosis, proliferation, and metastasis pathways in vivo and in vitro. J Agric Food Chem. 2018;67(2):625-36.

  16. Sakthivel KM, Guruvayoorappan C. Acacia ferruginea inhibits cyclophosphamide-induced immunosuppression and urotoxicity by modulating cytokines in mice. J Immunotoxicol. 2015;12(2):154-63.

  17. Thummar VR, Parasuraman S, Basu D, Raveendran R. Evaluation of in vivo antitumor activity of cleistanthin B in Swiss albino mice. J Tradit Complement Med. 2016;6(4):383-8.

  18. Kuppusamy S, Thavamani P, Megharaj M, Nirola R, Lee YB, Naidu R. Assessment of antioxidant activity, minerals, phenols and flavonoid contents of common plant/tree waste extracts. Ind Crops Prod. 2016;83(1):630-4.

  19. Bowen Forbes CS, Zhang Y, Nair MG. Anthocyanin con-tent, antioxidant, anti-inflammatory and anticancer properties of blackberry and raspberry fruits. J Food Compost Anal. 2010;23(6):554-60.

  20. Li D, Zhang Y, Liu Y, Sun R, Xia M. Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients. Nutr J. 2015;145(4):742-8.

  21. Thoppil RJ, Bhatia D, Barnes KF, Haznagy-Radnai E, Hohmann J, Darvesh AS, Bishayee A. Black currant antho-cyanins abrogate oxidative stress through Nrf2-mediated antioxidant mechanisms in a rat model of hepatocellular carcinoma. Curr Cancer Drug Target. 2012;12(9):1244-57.

  22. Anand K, Asthana P, Kumar A, Ambasta RK, Kumar P. Quercetin mediated reduction of angiogenic markers and chaperones in DLA-induced solid tumors. Asian Pac J Cancer Prev. 2011;12(1):2829-35.

  23. Dahiru D, Obidoa O. Evaluation of the antioxidant effects of Ziziphus mauritiana lam. leaf extracts against chronic ethanol-induced hepatotoxicity in rat liver. Afr J Tradit Complement Altern Med. 2008;5(1):39-45.

  24. Zhang M, Ning G, Shou C, Lu Y, Hong D, Zheng X. Inhibitory effect of jujuboside A on glutamate-mediated excitatory signal pathway in hippocampus. Planta Med. 2003;69(8):692-5.

  25. Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitric oxide: A review. Mutat Res Genet Toxicol. 1995;339(2):73-89.

  26. Vannini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox Biol. 2015;6(1):334-43.

  27. Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharm Sin. 2008;29(11):1275-88.

  28. Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 2002;13(2):135-41.

  29. Balkwill F. Tumor necrosis factor and cancer. Nat Rev Cancer. 2009;9(5):361-71.

  30. Grivennikov SI, Karin M. Inflammatory cytokines in cancer: Tumor necrosis factor and interleukin 6 take the stage. Ann Rheu Dis. 2011;70(1):104-8.

  31. Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016;37(9):11553-72.

  32. Hyun JW, Chung HS. Cyanidin and malvidin from Oryza sativa cv. Heugjinjubyeo mediate cytotoxicity against human monocytic leukemia cells by arrest of G2/M phase and induction of apoptosis. J Agric Food Chem. 2004;52(8):2213-17.

  33. Patterson SJ, Fischer JG, Dulebohn RV. DNA damage in HT-29 colon cancer cells is enhanced by high concentrations of the anthocyanin Maldivin. FASEB J. 2008; 22(1):890-910.

CITÉ PAR
  1. Gupta Swati Prabha, Tiwari Priyanka, Sharma Bechan, Protective Effect of Methanolic Extract of Euglena tuba Against Dalton Lymphoma Induced Oxidative Stress in BALB/c Mice, Indian Journal of Clinical Biochemistry, 2021. Crossref

  2. Zou Wenlan, Zhang Chen, Gu Xuefang, Li Xiaohong, Zhu Huiming, Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats, Drug Design, Development and Therapy, Volume 15, 2021. Crossref

1134 Vues d'articles 312 Téléchargements d'articles Métrique
1134 VUES 312 TÉLÉCHARGEMENTS 2 Crossref CITATIONS Google
Scholar
CITATIONS

Articles avec un contenu similaire:

Troxerutin Abrogates Ischemic/Reperfusion-Induced Brain Injury through Ameliorating Oxidative Stress and Neuronal Inflammation by Inhibiting the Expression of NLRP3 in Sprague Dawley Rats Journal of Environmental Pathology, Toxicology and Oncology, Vol.40, 2021, issue 4
Shuai Jiang, Chao Gao, Vidya Devanathadesikan Seshadri, Vishnu Priya Veeraraghavan, Yunfei Song, Haoze Wu, Taotao Dou, Pengfei Hou
The Protective Role of Cirsilineol against Ovalbumin-Induced Allergic Rhinitis in Mice by Suppression of Inflammation and Oxidative Stress Journal of Environmental Pathology, Toxicology and Oncology, Vol.40, 2021, issue 3
Juanli Wang, Yajuan Xue, Erle Li, Juan Yan, Dong Wang
Protective Role of Curcumin and Flunixin Against Acetic Acid−Induced Inflammatory Bowel Disease via Modulating Inflammatory Mediators and Cytokine Profile in Rats Journal of Environmental Pathology, Toxicology and Oncology, Vol.34, 2015, issue 4
G BOOBALAN, Matukumalli Usha Rani, C.S.V. Satish Kumar, Alla Gopala Reddy, Rasakatla Dileep, Matham Vijay Kumar
Antitumor Effect of Culinary-Medicinal Oyster Mushroom, Pleurotus ostreatus (Jacq.: Fr.) P. Kumm., Derived Protein Fraction on Tumor-Bearing Mice Models International Journal of Medicinal Mushrooms, Vol.13, 2011, issue 5
Mohitosh Mandal, Birendra Behera, Sujit Kumar Bhutia, Swatilekha Maiti, Tapas K Maiti, Sanjaya Kumar Mallick
Betalain Alleviates Airway Inflammation in an Ovalbumin-Induced-Asthma Mouse Model via the TGF-β1/Smad Signaling Pathway Journal of Environmental Pathology, Toxicology and Oncology, Vol.40, 2021, issue 2
Rui Dai, Ningling Wang, Yan Wang
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain